- Scrip Originals
UK Cystic Fibrosis Gene Therapy Consortium
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From UK Cystic Fibrosis Gene Therapy Consortium
Fortress Biotech’s subsidiary will add the lentiviral gene therapy now in pair of Phase I/II trials to its pipeline. RXi partners with Karolinska to advance its self-delivering RNAi technology, while Avalon enlists Weill Cornell to enhance its CAR-T capabilities.
- Gene Therapy, Cell Therapy